Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pernilla Stridh

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Brain : a Journal of Neurology|November 6, 2023
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosisViktor Grut, Martin Biström, Jonatan Salzer, et al.
European Journal of Neurology|June 9, 2021
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control studyViktor Grut, Martin Biström, Jonatan Salzer, et al.
Annals of Neurology|March 3, 2017
The immune response of the human brain to abdominal surgeryAnton Forsberg, Simon Cervenka, Malin Jonsson Fagerlund, et al.
Environmental Epigenetics|May 27, 2026
DNA methylation mediates the multiple sclerosis onset risk associated with HHV-6 DNA positivityAlex Eisner, Steve Simpson-Yap, Daniel J Park, et al.
Plos Genetics|March 4, 2014
Natural polymorphisms in Tap2 influence negative selection and CD4∶CD8 lineage commitment in the ratJonatan Tuncel, Sabrina Haag, Anthony C Y Yau, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2019
MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysisEkaterina Kotelnikova, Narsis A Kiani, Dimitris Messinis, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis riskKatarina Tengvall, Jesse Huang, Cecilia Hellström, et al.
Journal of Neurology|September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Frontiers in Immunology|February 11, 2020
Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple SclerosisElin Engdahl, Rasmus Gustafsson, Jesse Huang, et al.
Annals of Neurology|September 27, 2023
A Genetic Risk Variant for Multiple Sclerosis Severity is Associated with Brain AtrophyChristiane Gasperi, Tun Wiltgen, Julian McGinnis, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Brain : a Journal of Neurology|November 6, 2023
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosisViktor Grut, Martin Biström, Jonatan Salzer, et al.
European Journal of Neurology|June 9, 2021
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control studyViktor Grut, Martin Biström, Jonatan Salzer, et al.
Annals of Neurology|March 3, 2017
The immune response of the human brain to abdominal surgeryAnton Forsberg, Simon Cervenka, Malin Jonsson Fagerlund, et al.
Environmental Epigenetics|May 27, 2026
DNA methylation mediates the multiple sclerosis onset risk associated with HHV-6 DNA positivityAlex Eisner, Steve Simpson-Yap, Daniel J Park, et al.
Plos Genetics|March 4, 2014
Natural polymorphisms in Tap2 influence negative selection and CD4∶CD8 lineage commitment in the ratJonatan Tuncel, Sabrina Haag, Anthony C Y Yau, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2019
MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysisEkaterina Kotelnikova, Narsis A Kiani, Dimitris Messinis, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis riskKatarina Tengvall, Jesse Huang, Cecilia Hellström, et al.
Journal of Neurology|September 12, 2024
Pharmacogenomics of clinical response to Natalizumab in multiple sclerosis: a genome-wide multi-centric association studyFerdinando Clarelli, Andrea Corona, Kimmo Pääkkönen, et al.
Frontiers in Immunology|February 11, 2020
Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple SclerosisElin Engdahl, Rasmus Gustafsson, Jesse Huang, et al.
Annals of Neurology|September 27, 2023
A Genetic Risk Variant for Multiple Sclerosis Severity is Associated with Brain AtrophyChristiane Gasperi, Tun Wiltgen, Julian McGinnis, et al.
Pageof 7